- Home
- / Intervacc
Intervacc
Stock Price
KR2.8
2024-10-29
Market Capitalization
KR212.1 M
2024-10-29
Revenue
KR20.1 M
FY, 2025
Intervacc Summary
Company Summary
- Overview
- Intervacc is a biotechnology company that engages in research and development of vaccines for animal health. It sells veterinary medicines, pharmaceutical medicines, bacterial diagnostics, and vitamins, and other products.
- Type
- Public
- Status
- Active
- Founded
- 1988
- Website
- https://intervacc.se
- Cybersecurity rating
Table of Contents
Intervacc Financials
Summary Financials
- Revenue (FY, 2025)
- kr20.1M
- Gross profit (FY, 2025)
- (kr9.3M)
- Net income (FY, 2025)
- (kr80.8M)
- Cash (FY, 2025)
- kr160.9M
- EBIT (FY, 2025)
- (kr83.5M)
- Enterprise value
- $51.3M
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026